Stevens Capital Management’s Amedisys AMED Stock Holding History

Stevens Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,309	Closed	-$270K	–	666
2018 Q4	$270K	Buy	+2,309	New	+$272K	0.01%	582
2018 Q1	–	Sell	-3,823	Closed	-$202K	–	723
2017 Q4	$202K	Buy	+3,823	New	+$201K	0.01%	734
2014 Q3	–	Sell	-33,429	Closed	-$560K	–	978
2014 Q2	$560K	Buy	+33,429	New	+$474K	0.02%	634
2014 Q1	–	Sell	-13,211	Closed	-$193K	–	1052
2013 Q4	$193K	Buy	+13,211	New	+$213K	0.01%	919

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Stevens Capital Management's AMED Position: Q1 2019 in Review

Stevens Capital Management sold out of Amedisys (AMED) in Q1 2019, closing a stake of 2,309 shares — an estimated $270K sold.

Stevens Capital Management first reported a position in AMED in Q4 2013 and held it in 4 quarters. The position peaked at $560K in Q2 2014. 317 funds tracked by Wall St. Rank hold AMED as of Q1 2019.

Stevens Capital Management reported no remaining Amedisys position as of Q1 2019 after selling out during the quarter.
Stevens Capital Management sold 2,309 Amedisys shares in Q1 2019, an estimated $270K.
Stevens Capital Management first reported a position in Amedisys in Q4 2013 and held it in 4 quarters.
Stevens Capital Management's Amedisys position peaked at $560K in Q2 2014.
317 funds tracked by Wall St. Rank held Amedisys as of Q1 2019.

Based on Stevens Capital Management's 13F filing for Q1 2019, filed 3 May 2019.